Literature DB >> 12014557

Myalgic encephalomyelitis--the dangers of Cartesian fundamentalism.

Michael Fitzpatrick1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12014557      PMCID： PMC1314314     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  16 in total

1.  Designing a consumer friendly practice.

Authors:  L Mann; D Chambers
Journal:  Aust Fam Physician       Date:  2001-03

2.  Clinical decision support, systems methodology, and telemedicine: their role in the management of chronic disease.

Authors:  E R Carson; D G Cramp; A Morgan; A V Roudsari
Journal:  IEEE Trans Inf Technol Biomed       Date:  1998-06

3.  Chronic fatigue report delayed as row breaks out over content.

Authors:  Lynn Eaton
Journal:  BMJ       Date:  2002-01-05

4.  Angiotensin blockade for hypertension: a promise fulfilled.

Authors:  Hans R Brunner; Haralambos Gavras
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

5.  A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies.

Authors:  R H Green; D Watson; S Buchanan; A E Morrison
Journal:  Transfus Apher Sci       Date:  2001-02       Impact factor: 1.764

6.  Computer use must not affect doctor-patient relationship.

Authors:  A Thornett
Journal:  BMJ       Date:  2001-06-02

7.  General practice on the Internet.

Authors:  M Kidd
Journal:  Aust Fam Physician       Date:  2001-04

Review 8.  Has general practitioner computing made a difference to patient care? A systematic review of published reports.

Authors:  F Sullivan; E Mitchell
Journal:  BMJ       Date:  1995-09-30

Review 9.  Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.

Authors:  P Whiting; A M Bagnall; A J Sowden; J E Cornell; C D Mulrow; G Ramírez
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

10.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.